Screening for Circulating Tumour Cells Allows Early Detection of Cancer and Monitoring of Treatment Effectiveness: An Observational Study

BACKGROUND: Circulating-Tumour-Cells (CTC) provide a blood biomarker for early carcinogenesis, cancer progression and treatment effectiveness. An increase in CTCs is associated with cancer progression, a CTC decrease with cancer containment or remission. Several technologies have been developed to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ried, Karin, Eng, Peter, Sali, Avni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697492/
https://www.ncbi.nlm.nih.gov/pubmed/28843267
http://dx.doi.org/10.22034/APJCP.2017.18.8.2275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697492/
https://www.ncbi.nlm.nih.gov/pubmed/28843267
http://dx.doi.org/10.22034/APJCP.2017.18.8.2275

Ejemplares similares